Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Pruc

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Kardiologia Polska|March 12, 2026
Testosterone replacement therapy and non‑major adverse cardiovascular events safety signals: Atrial fibrillation, acute kidney injury, and pulmonary embolismLukasz Szarpak, Maciej Maslyk, Halla Kaminska, et al.
Polish Archives of Internal Medicine|May 5, 2026
Potassium-competitive acid blockers for erosive reflux disease and stress ulcer prophylaxis: a narrative reviewAndrea Denegri, Michal Pruc, Pawel Kozyra, et al.
Journal of Clinical Medicine|September 27, 2025
Does the Vaginal Microbiota Influence the Incidence of the Preterm Premature Rupture of Membranes?Stepan Feduniw, Natalia Zeber-Lubecka, Michal Pruc, et al.
Pharmacopsychiatry|April 17, 2025
Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional AnalysisDamian Swieczkowski, Aleksander Kwaśny, Michal Pruc, et al.
International Journal of Psychiatry in Medicine|April 25, 2025
Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysisDamian Swieczkowski, Aleksander Kwaśny, Michal Pruc, et al.
Medical Hypotheses|June 21, 2020
Kawasaki disease shock syndrome or toxic shock syndrome in children and the relationship with COVID-19Michal Pruc, Jacek Smereka, Tomasz Dzieciatkowski, et al.
Journal of Psychopharmacology (Oxford, England)|July 11, 2025
Unequal representation? A cross-sectional analysis of age, sex, race, and ethnicity in clinical trials of classic psychedelicsDamian Swieczkowski, Aleksander Kwaśny, Patrycja Ciurkowska, et al.
Therapeutic Innovation & Regulatory Science|March 28, 2026
Ethical and Regulatory Awareness of Clinical Trials: A Nationwide Cross-Sectional Study from PolandDamian Swieczkowski, Jacek Burzyński, Aleksander Kwaśny, et al.
Psychiatry Research|January 4, 2025
Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trialsDamian Swieczkowski, Aleksander Kwaśny, Michal Pruc, et al.
Journal of Clinical Medicine|December 23, 2023
Predictive Performance of Neuron-Specific Enolase (NSE) for Survival after Resuscitation from Cardiac Arrest: A Systematic Review and Meta-AnalysisKrzysztof Kurek, Damian Swieczkowski, Michal Pruc, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Kardiologia Polska|March 12, 2026
Testosterone replacement therapy and non‑major adverse cardiovascular events safety signals: Atrial fibrillation, acute kidney injury, and pulmonary embolismLukasz Szarpak, Maciej Maslyk, Halla Kaminska, et al.
Polish Archives of Internal Medicine|May 5, 2026
Potassium-competitive acid blockers for erosive reflux disease and stress ulcer prophylaxis: a narrative reviewAndrea Denegri, Michal Pruc, Pawel Kozyra, et al.
Journal of Clinical Medicine|September 27, 2025
Does the Vaginal Microbiota Influence the Incidence of the Preterm Premature Rupture of Membranes?Stepan Feduniw, Natalia Zeber-Lubecka, Michal Pruc, et al.
Pharmacopsychiatry|April 17, 2025
Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional AnalysisDamian Swieczkowski, Aleksander Kwaśny, Michal Pruc, et al.
International Journal of Psychiatry in Medicine|April 25, 2025
Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysisDamian Swieczkowski, Aleksander Kwaśny, Michal Pruc, et al.
Medical Hypotheses|June 21, 2020
Kawasaki disease shock syndrome or toxic shock syndrome in children and the relationship with COVID-19Michal Pruc, Jacek Smereka, Tomasz Dzieciatkowski, et al.
Journal of Psychopharmacology (Oxford, England)|July 11, 2025
Unequal representation? A cross-sectional analysis of age, sex, race, and ethnicity in clinical trials of classic psychedelicsDamian Swieczkowski, Aleksander Kwaśny, Patrycja Ciurkowska, et al.
Therapeutic Innovation & Regulatory Science|March 28, 2026
Ethical and Regulatory Awareness of Clinical Trials: A Nationwide Cross-Sectional Study from PolandDamian Swieczkowski, Jacek Burzyński, Aleksander Kwaśny, et al.
Psychiatry Research|January 4, 2025
Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trialsDamian Swieczkowski, Aleksander Kwaśny, Michal Pruc, et al.
Journal of Clinical Medicine|December 23, 2023
Predictive Performance of Neuron-Specific Enolase (NSE) for Survival after Resuscitation from Cardiac Arrest: A Systematic Review and Meta-AnalysisKrzysztof Kurek, Damian Swieczkowski, Michal Pruc, et al.
Pageof 9